112 related articles for article (PubMed ID: 3901614)
1. Active immunization of NMRI mice against Serratia marcescens.
Traub WH; Spohr M; Bauer D
Zentralbl Bakteriol Mikrobiol Hyg A; 1985 May; 259(3):410-25. PubMed ID: 3901614
[TBL] [Abstract][Full Text] [Related]
2. Active immunization of NMRI mice against Serratia marcescens. II. K-antigen extracts.
Traub WH; Spohr M; Bauer D
Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Dec; 267(2):228-46. PubMed ID: 3328927
[TBL] [Abstract][Full Text] [Related]
3. Active immunization of NMRI mice against Serratia marcescens. I. Phenol-water lipopolysaccharide fractions and purified metalloproteases.
Traub WH; Spohr M; Bauer D
Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Jun; 265(1-2):182-96. PubMed ID: 3314256
[TBL] [Abstract][Full Text] [Related]
4. Virulence of nosocomial isolates of Serratia marcescens for NMRI mice: correlation with O-antigens O6 and O14.
Traub WH
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jul; 252(3):360-9. PubMed ID: 6182709
[TBL] [Abstract][Full Text] [Related]
5. Passive protection of NMRI mice against Serratia marcescens: comparative efficacy of commercial human IgG immunoglobulin preparations and rabbit anti-O, -H, -K, -life cell and -protease immune sera.
Traub WH
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Jul; 254(4):480-8. PubMed ID: 6202079
[TBL] [Abstract][Full Text] [Related]
6. O-antigen specificities of the serotype strains of Serratia marcescens.
Gaston MA; Pitt TL
J Clin Microbiol; 1989 Dec; 27(12):2697-701. PubMed ID: 2480361
[TBL] [Abstract][Full Text] [Related]
7. Interactions of purified Serratia marcescens metalloproteases with fresh human serum and with purified human serum proteins.
Traub WH; Bauer D
Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Mar; 263(4):561-71. PubMed ID: 2440202
[TBL] [Abstract][Full Text] [Related]
8. Improved O-serotyping method for Serratia marcescens.
Gaston MA; Pitt TL
J Clin Microbiol; 1989 Dec; 27(12):2702-5. PubMed ID: 2480362
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic resistance and putative virulence factors of Serratia marcescens with respect to O and K serotypes.
Aucken HM; Pitt TL
J Med Microbiol; 1998 Dec; 47(12):1105-13. PubMed ID: 9856647
[TBL] [Abstract][Full Text] [Related]
10. Passive protection of NMRI mice with commercial, intravenously applicable human immunoglobulin IgG preparations against Serratia marcescens.
Traub WH
Chemotherapy; 1986; 32(6):530-6. PubMed ID: 3542407
[TBL] [Abstract][Full Text] [Related]
11. [Antigenic study of "Serratia marcescens" isolated in France.II.--Characterization of O antigens and description of 5 new O factors, occurrence of serotypes and labelling of new H factors (author's transl)].
Le Minor S; Pigache F
Ann Microbiol (Paris); 1978 Oct; 129 B(3):407-23. PubMed ID: 85425
[TBL] [Abstract][Full Text] [Related]
12. Immunochemical characterization of the outer membrane complex of Serratia marcescens and identification of the antigens accessible to antibodies on the cell surface.
Jessop HL; Lambert PA
J Gen Microbiol; 1985 Sep; 131(9):2343-8. PubMed ID: 2999300
[TBL] [Abstract][Full Text] [Related]
13. Different O and K serotype distributions among clinical and environmental strains of Serratia marcescens.
Aucken HM; Pitt TL
J Med Microbiol; 1998 Dec; 47(12):1097-104. PubMed ID: 9856646
[TBL] [Abstract][Full Text] [Related]
14. Resistance-plasmid- and protease-independent murine virulence of a multiple-drug-resistant strain of Serratia marcescens.
Traub WH; Spohr M; Bauer D
Zentralbl Bakteriol Mikrobiol Hyg A; 1983 Dec; 256(2):184-95. PubMed ID: 6369833
[TBL] [Abstract][Full Text] [Related]
15. Structural studies of glucorhamnans isolated from the lipopolysaccharides of reference strains for Serratia marcescens serogroups O4 and O7, and of an O14 strain.
Oxley D; Wilkinson SG
Carbohydr Res; 1988 Apr; 175(1):111-7. PubMed ID: 3288341
[TBL] [Abstract][Full Text] [Related]
16. Serotyping of Serratia marcescens using passive haemagglutination.
Guinée PA; Jansen WH; Maas HM
Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Apr; 264(1-2):105-19. PubMed ID: 2442923
[TBL] [Abstract][Full Text] [Related]
17. The role of surface polysaccharide in determining the resistance of Serratia marcescens to serum killing.
Jessop HL; Lambert PA
J Gen Microbiol; 1986 Sep; 132(9):2505-14. PubMed ID: 3540205
[TBL] [Abstract][Full Text] [Related]
18. [Epidemiological evaluation of Serratia marcescens clinical isolates in a general hospital during the past three years: appearance of O-antigens O2 and O14].
Marumo K; Nakamura Y; Sakurai C
Rinsho Byori; 1998 Jul; 46(7):728-33. PubMed ID: 9721543
[TBL] [Abstract][Full Text] [Related]
19. Serological relationships of the O antigens of Klebsiella pneumoniae O5, Escherichia coli O8 and a new O serotype of Serratia marcescens.
Aucken HM; Pitt TL
FEMS Microbiol Lett; 1991 May; 64(1):93-7. PubMed ID: 1713181
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of specific immunological unresponsiveness to bacterial lipopolysaccharides.
Elkins KL; Stashak PW; Baker PJ
Infect Immun; 1987 Dec; 55(12):3093-102. PubMed ID: 3316032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
